Species-Specific Detection of C. difficile Using Targeted Antibody Design

Area of Science:

• Microbiology
• Immunology
• Biotechnology

Background:

• Clostridium difficile infections pose a significant global healthcare challenge, complicated by diagnostic difficulties.
• Current diagnostic methods for C. difficile infection vary in effectiveness, necessitating improved approaches.

Purpose of the Study:

• To identify a novel, species-specific biomarker for Clostridium difficile.
• To develop affinity reagents and a diagnostic assay for improved C. difficile infection detection.

Main Methods:

• A bioinformatics pipeline identified a unique surface-associated biomarker (AKDGSTKEDQLVDALA).
• Monoclonal antibodies were generated against the biomarker peptide sequence.
• Surface plasmon resonance characterized antibody-target binding kinetics and assay sensitivity.

Main Results:

• Monoclonal antibody 521 (mAb521) demonstrated specific binding to all C. difficile surface layer types, not cross-reacting with related strains.
• An apparent equilibrium dissociation constant of 36.5 nM was determined for mAb521 and the target protein.
• The diagnostic assay achieved a limit of detection of 12.4 ng/mL for the target protein and 1.7 × 10^6 cells/mL for C. difficile cultures.

Conclusions:

• A computational approach enabled the design of species-specific antibodies for diagnostic applications.
• The developed mAb521 and assay offer a promising tool for accurate and reliable C. difficile detection.
• This strategy mitigates false-positive results by targeting a unique biomarker, enhancing diagnostic specificity.